| 1. | answerboy79 | |
| 2. | wjohenning2756 | |
| 3. | spottedgecko7 | |
| 4. | mevol77 | |
| 5. | jcherolis |
Top Board Researchers
These are the top researchers based on quality of posts as voted by board members. Typically they know their stuff and are a great
way to catch up on what the company is all about.
HOW DO I BECOME ONE?
Just do great research! As other members approve of your posts, you earn points that move you up the ranks.| 1. | wjohenning2756 02/21/2018 Announces publication of the results from the Phase 1 |
| 2. | wjohenning2756 06/04/2018 TG Therapeutics, Inc. Announces Umbralisib Clinical Data Presentation at the 54th Annual Meeting of the American Society of Clinical Oncology |
| 3. | answerboy79 02/21/2018 I bought in over a year ago |
| 4. | spottedgecko7 01/08/2018 Facts - TG Therapeutics and Jiangsu Hengrui Medicine Announce Global License Agreement for Development and Commercialization of Novel BTK Inhibitor Program for the Treatment of Hematologic Malignancie |
| 5. | mevol77 04/24/2018 TG Therapeutics, Inc. Announces Updated Results from the Ongoing Phase 2 Study of Ublituximab (TG-1101) in Patients with Multiple Sclerosis at the American Academy of Neurology 70th Annual Meeting |
| 6. | zbzapp95 02/21/2018 Seems like $20 getting closer every day |
| 7. | jcherolis 06/04/2018 Top Analyst Weighs in on TG Therapeutics (TGTX) Following Encouraging ASCO Update |
| 8. | answerboy79 02/21/2018 The bid is strong. Good depth |
| 9. | answerboy79 02/05/2018 More details |
| 10. | spottedgecko7 02/21/2018 watching for more {Image} |
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW
TG Therapeutics, Inc.
- TGTX
- Public Stock Message Board
Filtering by:
-
To use your chart in a post, click the
icon above the chart. From there you can get the chart link or download the image.